Network-Based Metabolism-Centered Screening of Potential Drug Targets in Klebsiella pneumoniae at Genome Scale

dc.contributor.authorCesur, Muberra Fatma
dc.contributor.authorSiraj, Bushra
dc.contributor.authorUddin, Real
dc.contributor.authorDurmus, Saliha
dc.contributor.authorÇakır, Tunahan
dc.date.accessioned2025-10-29T11:09:10Z
dc.date.issued2020
dc.departmentFakülteler, Mühendislik Fakültesi, Biyomühendislik Bölümü
dc.description.abstractKlebsiella pneumoniae is an opportunistic bacterial pathogen leading to life-threatening nosocomial infections. Emergence of highly resistant strains poses a major challenge in the management of the infections by healthcare-associated K. pneumoniae isolates. Thus, despite intensive efforts, the current treatment strategies remain insufficient to eradicate such infections. Failure of the conventional infection-prevention and treatment efforts explicitly indicates the requirement of new therapeutic approaches. This prompted us to systematically analyze the K. pneumoniae metabolism to investigate drug targets. Genome-scale metabolic networks (GMNs) facilitating the systematic analysis of the metabolism are promising platforms. Thus, we used a GMN of K. pneumoniae MGH 78578 to determine putative targets through gene- and metabolite-centric approaches. To develop more realistic infection models, we performed the bacterial growth simulations within different host-mimicking media, using an improved biomass formation reaction. We selected more suitable targets based on several property-based prioritization procedures. KdsA was identified as the high-ranked putative target satisfying most of the target prioritization criteria specified under the gene-centric approach. Through a structure-based virtual screening protocol, we identified potential KdsA inhibitors. In addition, the metabolite-centric approach extended the drug target list based on synthetic lethality. This revealed the importance of combined metabolic analyses for a better understanding of the metabolism. To our knowledge, this is the first comprehensive effort on the investigation of the K. pneumoniae metabolism for drug target prediction through the constraint-based analysis of its GMN in conjunction with several bioinformatic approaches. This study can guide the researchers for the future drug designs by providing initial findings regarding crucial components of the Klebsiella metabolism.
dc.description.sponsorshipTUBITAK, The Scientific and Technological Research Council of Turkey [316S005]
dc.description.sponsorshipPSF, The Pakistan Science Foundation [PSF-TUBITAK/S-HEJ (04)]
dc.description.sponsorshipThis work was supported by TUBITAK, The Scientific and Technological Research Council of Turkey (Project Code: 316S005) and by PSF, The Pakistan Science Foundation [Project Code: PSF-TUBITAK/S-HEJ (04)].
dc.identifier.doi10.3389/fcimb.2019.00447
dc.identifier.issn2235-2988
dc.identifier.orcid0000-0001-8262-4420
dc.identifier.orcid0000-0003-2993-0634
dc.identifier.orcid0000-0002-9928-4482
dc.identifier.pmid31993376
dc.identifier.scopus2-s2.0-85078688021
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3389/fcimb.2019.00447
dc.identifier.urihttps://hdl.handle.net/20.500.14854/5694
dc.identifier.volume9
dc.identifier.wosWOS:000510646000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherFrontiers Media Sa
dc.relation.ispartofFrontiers in Cellular and Infection Microbiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20251020
dc.subjectKlebsiella pneumoniae
dc.subjectinfection
dc.subjectgenome-scale metabolic networks
dc.subjectpathogen
dc.subjectflux balance analysis
dc.subjectdrug target
dc.titleNetwork-Based Metabolism-Centered Screening of Potential Drug Targets in Klebsiella pneumoniae at Genome Scale
dc.typeArticle

Dosyalar